Genetic Technologies Ltd (NASDAQ:GENE)

4.42
Delayed Data
As of May 01
 0.00 / 0.00%
Today’s Change
1.04
Today|||52-Week Range
11.00
+129.55%
Year-to-Date
Institutional investors purchased a net $2.3 million shares of GENE during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 20.18% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders--
Individual stakeholders--
Other institutional--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

3/06/2015SABBY CAPITAL LLC  Bought 1.1 Million shares of Genetic Technologies Ltd
3/06/2015HEIGHTS CAPITAL MANAGEMENT, INC.  Bought 1.1 Million shares of Genetic Technologies Ltd
3/31/2015CREATIVE PLANNING, INC.  Bought 850.00 shares of Genetic Technologies Ltd

Top 10 Owners of Genetic Technologies Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Sabby Capital LLC9.72%1,111,1115,855,555+1,111,111--
Heights Capital Management, Inc.9.72%1,111,1115,855,555+1,111,111--
Renaissance Technologies LLC0.52%58,800309,876+37,040+170.22%
Thompson Davis & Co., Inc.0.12%13,80072,726+13,800--
Columbia Management Investment Ad...0.04%4,58224,147+1,652+56.38%
KCG Americas LLC0.03%3,93920,759-10,810-73.29%
Alpine Securities USVI LLC0.02%2,22011,69900.00%
Creative Planning, Inc.0.01%8504,480+850--
Morgan Stanley & Co. LLC0.00%421+1+33.33%
Citadel Advisors LLC0.00%00-2,955-100.00%

Top 10 Mutual Funds Holding Genetic Technologies Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change

To view my watchlist

Not a member yet?

Sign up now for a free account